Hydrolysis by cathepsin B of fluorescent peptides derived from human prorenin.
暂无分享,去创建一个
[1] A. Danser,et al. Cardiac renin and angiotensins. Uptake from plasma versus in situ synthesis. , 1994, Hypertension.
[2] N. Niedermaier,et al. Cardiac angiotensinogen and its local activation in the isolated perfused beating heart. , 1990, Circulation research.
[3] R. Coulombe,et al. RAT PROCATHEPSIN B , 1997 .
[4] N. Fukuda,et al. Production of angiotensin II by homogeneous cultures of vascular smooth muscle cells from spontaneously hypertensive rats. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[5] A. Berger,et al. On the size of the active site in proteases. I. Papain. , 1967, Biochemical and biophysical research communications.
[6] J. Habener,et al. Angiotensinogen gene is expressed and differentially regulated in multiple tissues of the rat. , 1986, The Journal of clinical investigation.
[7] C. Krakower,et al. Direct evidence for the antigenicity of the glomeruli in the production of nephrotoxic serums. , 1950, A.M.A. archives of pathology.
[8] I. Jutras,et al. Prorenin activation and prohormone convertases in the mouse As4.1 cell line. , 1997, Kidney international.
[9] J. Baxter,et al. Molecular determinants of human prorenin processing. , 1992, Hypertension.
[10] T. Brody,et al. Tissue‐Specific Regulation of Renin Expression in the Mouse , 1987, Hypertension.
[11] J. Baxter,et al. A Protease Processing Site Is Essential for Prorenin Sorting to the Regulated Secretory Pathway* , 1996, The Journal of Biological Chemistry.
[12] I. Jutras,et al. Prohormone convertase PC5 is a candidate processing enzyme for prorenin in the human adrenal cortex. , 1996, Hypertension.
[13] E. Shaw,et al. [2] Titration of trypsin, plasmin, and thrombin with p-nitrophenyl p′-guanidinobenzoate HCl☆ , 1970 .
[14] A. Danser,et al. Renin-angiotensin system components in the interstitial fluid of the isolated perfused rat heart. Local production of angiotensin I. , 1997, Hypertension.
[15] M. Schalekamp,et al. Human prorenin: pathophysiology and clinical implications. , 1988, Clinical and experimental hypertension. Part A, Theory and practice.
[16] M. Schalekamp,et al. An intrinsic factor XII–prekallikrein-dependent pathway activates the human plasma renin–angiotensin system , 1979, Nature.
[17] W. Ganong,et al. Analysis by immunocytochemistry and in situ hybridization of renin and its mRNA in kidney, testis, adrenal, and pituitary of the rat. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[18] D. Casarini,et al. Purification and characterization of angiotensin I‐converting enzymes from mesangial cells in culture , 1998, Journal of hypertension.
[19] H. Thurston,et al. Arterial wall uptake of renal renin and blood pressure control. , 1983, Hypertension.
[20] W. Hsueh,et al. Human Prorenin , 1991, Hypertension.
[21] J. Berrou,et al. Specific receptor binding of renin on human mesangial cells in culture increases plasminogen activator inhibitor-1 antigen. , 1996, Kidney international.
[22] J. Mort,et al. Rat procathepsin B. Proteolytic processing to the mature form in vitro. , 1992, The Journal of biological chemistry.
[23] A. Danser,et al. Mannose 6-phosphate receptor-mediated internalization and activation of prorenin by cardiac cells. , 1997, Hypertension.
[24] R. Ardaillou,et al. Identification and regulation of renin in human cultured mesangial cells. , 1987, The American journal of physiology.
[25] L. Chao,et al. Specificity of human tissue kallikrein towards substrates containing Phe-Phe pair of amino acids. , 1999, Biochemical Journal.
[26] G. N. Wilkinson. Statistical estimations in enzyme kinetics. , 1961, The Biochemical journal.
[27] J. Laragh,et al. Human urinary kallikrein converts inactive to active renin and is a possible physiological activator of renin , 1978, Nature.
[28] R. Ménard,et al. Major increase in endopeptidase activity of human cathepsin B upon removal of occluding loop contacts. , 1997, Biochemistry.
[29] J. Saris,et al. Cultured neonatal rat cardiac myocytes and fibroblasts do not synthesize renin or angiotensinogen: evidence for stretch-induced cardiomyocyte hypertrophy independent of angiotensin II. , 1999, Cardiovascular research.
[30] W. Ganong. Blood, Pituitary, and Brain Renin-Angiotensin Systems and Regulation of Secretion of Anterior Pituitary Gland , 1993, Frontiers in Neuroendocrinology.
[31] W. Hsueh,et al. Identification of renal cathepsin B as a human prorenin-processing enzyme. , 1991, The Journal of biological chemistry.
[32] I. Jutras,et al. Prorenin processing by cathepsin B in vitro and in transfected cells , 1999, FEBS letters.
[33] W. Rutter,et al. Redesigning trypsin: alteration of substrate specificity. , 1985, Science.
[34] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[35] A. Barrett,et al. Cathepsin B, Cathepsin H, and cathepsin L. , 1981, Methods in enzymology.
[36] Alan J. Barrett,et al. [41] Cathepsin B, cathepsin H, and cathepsin L , 1981 .
[37] C. L. Dias,et al. Autolysis of beta-trypsin at pH 3.0. , 1986, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[38] A. Barrett. Fluorimetric assays for cathepsin B and cathepsin H with methylcoumarylamide substrates. , 1980, The Biochemical journal.
[39] F. A. Neves,et al. Cathepsin B is a prorenin processing enzyme. , 1996, Hypertension.